| Expression pattern: |
UP |
| Associated gene: |
BCL2, BCL2L1, CASP8, CASP9 |
| Associated microRNA: |
- |
| Biological function: |
Sodium arsenite-mediated upregulation of circDHX34 promotes apoptosis and represses proliferation in hormone-independent breast cancer MDA-MB-231 cells; knockdown of circDHX34 promotes cell proliferation and inhibits apoptosis. |
| Molecular mechanism: |
circDHX34 regulates apoptotic genes: knockdown upregulates antiapoptotic genes BCL2 and BCL2L1 and downregulates proapoptotic genes CASP8 and CASP9. |
| Biological pathway or process: |
apoptosis (promotes); proliferation (inhibits) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Transfection; CCK8 |
| Clinical significance: |
- |
| Description: |
In sodium arsenite-treated hormone-independent breast cancer MDA-MB-231 cells, circDHX34 is up-regulated in a dose-dependent manner. Functional knockdown experiments indicate that circDHX34 suppresses proliferation and promotes apoptosis, likely through regulation of apoptotic genes including BCL2, BCL2L1, CASP8 and CASP9. |
| Confidence score: |
0.3513 |